Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-24
2007-07-24
Morris, Patricia L. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S238000
Reexamination Certificate
active
11151897
ABSTRACT:
Compounds of Formula (I)are effective in the treatment of a microbial infection.
REFERENCES:
patent: 3853900 (1974-12-01), Shone et al.
patent: 5358949 (1994-10-01), Tabusa et al.
patent: 5407948 (1995-04-01), Fey et al.
patent: 5849587 (1998-12-01), Hanauske-Abel et al.
patent: 6046219 (2000-04-01), Hanauske-Abel et al.
patent: 6080766 (2000-06-01), Hanauske-Abel et al.
Muellner, F.W. et al., “The Synthesis of 1,4-ethano-1,2,3,4-tetrahydroisoquinolines as rigid analogues of adrenergic agents”,J of Heterocyclic Chemistry, 1983, vol. 20 pp. 1581-1584.
Bush Rodney Dean
Warshokoon Namal Chithranga
Morris Patricia L.
Paul Andrew A.
The Procter & Gamble & Company
Upite David V.
LandOfFree
N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3720656